These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Procollagen I N-terminal peptide correlates with inflammation on sacroiliac joint magnetic resonance imaging in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis: A cross-sectional study. Li X, Liang A, Chen Y, Lam NS, Long X, Xu X, Zhong S. Mod Rheumatol; 2022 Jul 01; 32(4):770-775. PubMed ID: 34897520 [Abstract] [Full Text] [Related]
5. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study. Kilic E, Kilic G, Akgul O, Ozgocmen S. Rheumatol Int; 2015 Jun 01; 35(6):981-9. PubMed ID: 25366469 [Abstract] [Full Text] [Related]
6. Is there any gender-specific difference in the cut-off values of ankylosing spondylitis disease activity score in patients with axial spondyloarthritis? Kilic G, Kilic E, Ozgocmen S. Int J Rheum Dis; 2017 Sep 01; 20(9):1201-1211. PubMed ID: 27309497 [Abstract] [Full Text] [Related]
10. Exploratory analysis of the potential disconnect between objective inflammatory response and clinical response following certolizumab pegol treatment in patients with active axial spondyloarthritis. Rudwaleit M, Marzo-Ortega H, Navarro-Compán V, Tham R, Kumke T, Bauer L, de Peyrecave N, Kim M, Van den Bosch F. RMD Open; 2024 Aug 28; 10(3):. PubMed ID: 39209369 [Abstract] [Full Text] [Related]
12. Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors. Pedersen SJ, Sørensen IJ, Hermann KG, Madsen OR, Tvede N, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen K, Johansen JS, Jurik AG, Møller J, Hasselquist M, Mikkelsen D, Skjødt T, Hansen A, Ostergaard M. Ann Rheum Dis; 2010 Jun 28; 69(6):1065-71. PubMed ID: 19740906 [Abstract] [Full Text] [Related]
14. Validity of the ankylosing spondylitis disease activity score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme. Fernández-Espartero C, de Miguel E, Loza E, Tomero E, Gobbo M, Descalzo MA, Collantes-Estévez E, Mulero J, Muñoz-Fernández S, Zarco P, Carmona L, ESPERANZA Study Group. Ann Rheum Dis; 2014 Jul 28; 73(7):1350-5. PubMed ID: 23709245 [Abstract] [Full Text] [Related]
15. The value of SPARCC sacroiliac MRI scoring in axial psoriatic arthritis and its association with other disease parameters. Gezer HH, Duruöz MT. Int J Rheum Dis; 2022 Apr 28; 25(4):433-439. PubMed ID: 35080124 [Abstract] [Full Text] [Related]
16. Disease activity is longitudinally related to sacroiliac inflammation on MRI in male patients with axial spondyloarthritis: 2-years of the DESIR cohort. Navarro-Compán V, Ramiro S, Landewé R, Dougados M, Miceli-Richard C, Richette P, van der Heijde D. Ann Rheum Dis; 2016 May 28; 75(5):874-8. PubMed ID: 26403689 [Abstract] [Full Text] [Related]
19. Ankylosing spondylitis: correlations between clinical and MRI indices of sacroiliitis activity. Zhang P, Yu K, Guo R, Shah S, Morelli JN, Runge VA, Li X. Clin Radiol; 2015 Jan 28; 70(1):62-6. PubMed ID: 25459199 [Abstract] [Full Text] [Related]